Investigational Antifungal Agents

This publication has 34 references indexed in Scilit:

• In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies.
  Journal of Antimicrobial Chemotherapy, 2000
• In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients
  Journal of Antimicrobial Chemotherapy, 1999
• International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents
  Diagnostic Microbiology and Infectious Disease, 1999
• In Vitro Susceptibilities of Candida and Cryptococcus neoformans Isolates from Blood Cultures of Neutropenic Patients
  Antimicrobial Agents and Chemotherapy, 1999
• In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem
  Journal of Antimicrobial Chemotherapy, 1999
• Activity of MK-0991 (l-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
  Diagnostic Microbiology and Infectious Disease, 1998
• Successful Treatment with Voriconazole of Invasive Aspergillosis in Chronic Granulomatous Disease
  American Journal of Respiratory and Critical Care Medicine, 1998
• Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp.
  Diagnostic Microbiology and Infectious Disease, 1996
• ANTIBIOTICS THAT INHIBIT FUNGAL CELL WALL DEVELOPMENT
  Annual Review of Microbiology, 1994
• Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis
  Antimicrobial Agents and Chemotherapy, 1990